Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $108B |
| FY2017, ended Dec 31, 2017 | $125B |
| FY2018, ended Dec 31, 2018 | $121B |
| FY2019, ended Dec 31, 2019 | $142B |
| FY2020, ended Dec 31, 2020 | $133B |
| FY2021, ended Dec 31, 2021 | $125B |
| FY2022, ended Dec 31, 2022 | $140B |
| FY2023, ended Dec 31, 2023 | $154B |
| FY2024, ended Dec 31, 2024 | $140B |
| FY2025, ended Dec 31, 2025 | $176B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $196B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $23.0B |
| FY2017, ended Dec 31, 2017 | $22.8B |
| FY2018, ended Dec 31, 2018 | $23.7B |
| FY2019, ended Dec 31, 2019 | $23.4B |
| FY2020, ended Dec 31, 2020 | $25.4B |
| FY2021, ended Dec 31, 2021 | $26.0B |
| FY2022, ended Dec 31, 2022 | $26.3B |
| FY2023, ended Dec 31, 2023 | $28.2B |
| FY2024, ended Dec 31, 2024 | $33.4B |
| FY2025, ended Dec 31, 2025 | $36.8B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $38.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $7.72B | $9.62B |
| FY2017, ended Dec 31, 2017 | $1.98B | $10.5B |
| FY2018, ended Dec 31, 2018 | $8.39B | $10.6B |
| FY2019, ended Dec 31, 2019 | $7.84B | $8.53B |
| FY2020, ended Dec 31, 2020 | $7.26B | $9.89B |
| FY2021, ended Dec 31, 2021 | $5.89B | $8.38B |
| FY2022, ended Dec 31, 2022 | $6.55B | $8.79B |
| FY2023, ended Dec 31, 2023 | $6.72B | $7.36B |
| FY2024, ended Dec 31, 2024 | $4.09B | $10.4B |
| FY2025, ended Dec 31, 2025 | $7.71B | $8.10B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $8.74B | $10.2B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.24B |
| FY2017, ended Dec 31, 2017 | $3.80B |
| FY2018, ended Dec 31, 2018 | $6.95B |
| FY2019, ended Dec 31, 2019 | $6.04B |
| FY2020, ended Dec 31, 2020 | $6.27B |
| FY2021, ended Dec 31, 2021 | $7.99B |
| FY2022, ended Dec 31, 2022 | $7.63B |
| FY2023, ended Dec 31, 2023 | $10.9B |
| FY2024, ended Dec 31, 2024 | $12.0B |
| FY2025, ended Dec 31, 2025 | $9.13B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $14.0B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $34.6B |
| FY2017, ended Dec 31, 2017 | $35.3B |
| FY2018, ended Dec 31, 2018 | $33.9B |
| FY2019, ended Dec 31, 2019 | $29.9B |
| FY2020, ended Dec 31, 2020 | $33.0B |
| FY2021, ended Dec 31, 2021 | $33.3B |
| FY2022, ended Dec 31, 2022 | $38.9B |
| FY2023, ended Dec 31, 2023 | $64.6B |
| FY2024, ended Dec 31, 2024 | $60.1B |
| FY2025, ended Dec 31, 2025 | $54.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $57.3B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 26.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 736M |
| FY2017, ended Dec 31, 2017 | 721M |
| FY2018, ended Dec 31, 2018 | 622M |
| FY2019, ended Dec 31, 2019 | 590M |
| FY2020, ended Dec 31, 2020 | 578M |
| FY2021, ended Dec 31, 2021 | 557M |
| FY2022, ended Dec 31, 2022 | 534M |
| FY2023, ended Dec 31, 2023 | 536M |
| FY2024, ended Dec 31, 2024 | 537M |
| FY2025, ended Dec 31, 2025 | 539M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 541M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.96B | $311M | — |
| FY2017, ended Dec 31, 2017 | $3.16B | $329M | — |
| FY2018, ended Dec 31, 2018 | $17.8B | $311M | — |
| FY2019, ended Dec 31, 2019 | $7.70B | $308M | — |
| FY2020, ended Dec 31, 2020 | $3.49B | $330M | — |
| FY2021, ended Dec 31, 2021 | $4.97B | $341M | — |
| FY2022, ended Dec 31, 2022 | $6.36B | $401M | — |
| FY2023, ended Dec 31, 2023 | $0 | $431M | $141M |
| FY2024, ended Dec 31, 2024 | $200M | $530M | — |
| FY2025, ended Dec 31, 2025 | $0 | $494M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — | $492M | — |
Valuation
At current price- Market Cap
- $242B
- P/E
- 27.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.4×
- Price / Book
- 20.7×
- EV / EBITDA
- 17.7×
Growth
Trailing 12 months- Revenue (TTM)
- $38.1B
- Revenue Growth YoY
- 9.1%
- Revenue CAGR 3Y
- 11.8%
- Revenue CAGR 5Y
- 7.6%
- EPS Growth YoY
- 31.6%
- Net Income Growth YoY
- 32.1%
Profitability
Trailing 12 months- Gross Margin
- 69.5%
- Operating Margin
- 30.0%
- Net Margin
- 23.0%
- FCF Margin
- 26.7%
- Return on Equity
- 91.5%
Earnings
Trailing 12 months- Net Income
- $8.74B
- EPS (diluted)
- $16.10
- EBITDA
- $16.1B
- Operating Income
- $11.4B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $14.0B
- Total Debt
- $57.3B
- Net Debt
- $43.3B
- Total Assets
- $95.6B
- Total Liabilities
- $84.0B
- Shareholders' Equity
- $11.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $12.5B
- Capital Expenditure
- $2.30B
- Free Cash Flow
- $10.2B
Dividends and risk
Last 12 months- Dividend Yield
- 2.2%
- Dividend / Share
- $9.94
- Beta (5Y)
- 0.41
Every ratio is calculated from the company’s reported figures.